Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 20.80% and Operating profit at 37.40% over the last 5 years
2
The company has declared Positive results for the last 4 consecutive quarters
3
With ROE of 16.38%, it has a attractive valuation with a 4.75 Price to Book Value
4
Market Beating performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.64%
0%
14.64%
6 Months
20.94%
0%
20.94%
1 Year
50.72%
0%
50.72%
2 Years
70.31%
0%
70.31%
3 Years
100.64%
0%
100.64%
4 Years
201.86%
0%
201.86%
5 Years
0%
0%
0.0%
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
20.80%
EBIT Growth (5y)
37.40%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.57
Tax Ratio
10.65%
Dividend Payout Ratio
19.23%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.36%
ROE (avg)
13.03%
Valuation key factors
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
4.75
EV to EBIT
25.19
EV to EBITDA
19.01
EV to Capital Employed
5.37
EV to Sales
6.60
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
21.30%
ROE (Latest)
16.38%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
317.80
334.00
-4.85%
Operating Profit (PBDIT) excl Other Income
108.60
127.40
-14.76%
Interest
1.90
1.10
72.73%
Exceptional Items
0.00
0.10
-100.00%
Consolidate Net Profit
94.80
88.40
7.24%
Operating Profit Margin (Excl OI)
341.90%
302.40%
3.95%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is -4.85% vs 6.61% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is 7.24% vs 8.60% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,142.00
863.80
32.21%
Operating Profit (PBDIT) excl Other Income
338.60
240.90
40.56%
Interest
2.90
2.40
20.83%
Exceptional Items
1.30
2.70
-51.85%
Consolidate Net Profit
245.60
193.00
27.25%
Operating Profit Margin (Excl OI)
226.50%
223.90%
0.26%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 32.21% vs 20.17% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 27.25% vs 27.98% in Dec 2023
About Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. 
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
FMCG
No Details Available.
Company Coordinates 
No Company Details Available






